Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study

ConclusionsIn this interim analysis of OPAL Balance, tofacitinib safety and efficacy in patients with PsA appeared to be consistent with those of the P3 studies. Efficacy was maintained over time.Trial RegistrationClinicalTrials.gov identifier: NCT01976364.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research